![](https://www.pdfsearch.io/img/540970e05eb0bde3b687d57f7dbe1cdb.jpg) Date: 2018-07-18 19:08:19
| | PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for genoAdd to Reading ListSource URL: www.abbvie.caDownload Document from Source Website File Size: 328,56 KBShare Document on Facebook
|